Short answer: Pharmaceutical Field teams can automate 50–70% of their repetitive workflow with AI agents that integrate into existing systems in 2 weeks. Wednesday starts with a fixed-price evaluation sprint — if the prototype doesn't show a clear path to 50% cost reduction, you don't pay for the build.
Your medical reps work in hospital corridors and rural clinic parking lots where cellular coverage is unreliable. Your AI call summarization and next-best-action features fail at exactly the moment after a physician interaction when the rep needs them most.
Post-call documentation is time-sensitive. The 5-minute window after leaving a physician's office is when reps remember interaction details most clearly. An AI summarization tool that requires connectivity to function turns that window into a wait - and a wait at the end of a 10-call day becomes documentation that gets skipped.
What decisions determine whether this project ships in 6 weeks or 18 months?
Four decisions determine whether your field sales AI produces compliant, accurate call records or creates a documentation gap your medical affairs team discovers at audit.
FDA promotional compliance. AI-generated content in a pharmaceutical sales app is promotional material subject to FDA oversight. The model cannot produce off-label claims, comparative efficacy claims without citation to an approved study, or unsubstantiated safety or tolerability language. The content constraint architecture - the rules that govern what the model can and cannot output - has to be part of the model configuration before any output reaches a rep. A post-generation filter that removes non-compliant language is not sufficient: a filter that fails produces a non-compliant output the rep submits as a call record. The constraint has to be structural, not remedial.
Voice capture consent. Call summarization requires either real-time transcription during the interaction or post-call voice note capture. Healthcare professional interactions carry privacy expectations. State-by-state consent requirements for recording a conversation vary - California, Florida, and Illinois require two-party consent; most other states require one-party consent. The consent architecture in the app has to detect the rep's current location, surface the appropriate consent workflow, and log the consent before any recording begins. This is a legal requirement, not a UX preference.
CRM write-back. A call summary that doesn't automatically log to Veeva CRM, Salesforce Health Cloud, or your CRM platform of choice creates a parallel documentation step. The rep gets a summary and then manually copies it into the CRM. That step gets skipped when reps are running behind schedule, which is most days. The CRM integration has to be part of the delivery scope - not a follow-on project - or the AI generates summaries that don't live in the system of record.
Model accuracy on medical terminology. A general-purpose transcription and summarization model will mis-transcribe drug names, mechanism of action terms, receptor nomenclature, and dosing language. A summary that says "100 micrograms" when the rep said "100 milligrams" is a compliance problem, not a typo. The on-device model needs to be adapted for pharmaceutical terminology specific to your therapeutic area before it produces summaries a medical affairs team will approve for logging as official call records.
Most teams spend 4-6 months discovering these decisions by building the wrong version first. A team that has shipped this before compresses that to 1 week.
On-Device AI vs. Cloud AI: What's the Real Difference?
| Factor | On-Device AI | Cloud AI |
|---|---|---|
| Data transmission | None — data never leaves the device | All inputs sent to external server |
| Compliance | No BAA/DPA required for inference step | Requires BAA (HIPAA) or DPA (GDPR) |
| Latency | Under 100ms on Neural Engine | 300ms–2s (network + server queue) |
| Cost at scale | Fixed — one-time integration | Variable — $0.001–$0.01 per query |
| Offline capability | Full functionality, no connectivity needed | Requires active internet connection |
| Model size | 1B–7B parameters (quantized) | Unlimited (GPT-4, Claude 3, etc.) |
| Data sovereignty | Device-local, no cross-border transfer | Depends on server region and DPA chain |
The right choice depends on your compliance constraints, query volume, and task complexity. Wednesday scopes this in the first week — before any code is written.
Why is Wednesday the right team for on-device AI?
We built Off Grid because we hit every one of these problems in production. Off Grid is the fastest-growing on-device AI application in the world, with 50,000+ users running it today.
It's open source, with 1,650+ stars on GitHub and contributors from across the world. It has been cited in peer-reviewed clinical research on offline mobile edge AI.
Every decision named above - model choice, platform, server boundary, compliance posture - we have made before, at scale, for real deployments.
How long does the integration take, and what does it cost?
The engagement is four sprints. Each sprint is fixed-price. Each sprint has a named deliverable your team can put on a roadmap.
Discovery (Week 1, $5K): We resolve the four decisions - model, platform, server boundary, compliance posture. Deliverable: a 1-page architecture doc your CTO can take to the board and your Privacy Officer can take to Legal.
Integration (Weeks 2-3, $5K-$10K): We ship the on-device model into your app behind a feature flag. Deliverable: a working build your QA team can test against real workflows.
Optimization (Weeks 4-5, $5K-$10K): We hit the performance and compliance targets from the discovery doc. Deliverable: benchmarks signed off by your team.
Production hardening (Week 6, $5K): Edge cases, OS version coverage, app store and compliance review readiness. Deliverable: shippable build.
4-6 weeks total. $20K-$30K total.
Money back if we don't hit the benchmarks. We have not had to refund.
"Retention improved from 42% to 76% at 3 months. AI recommendations rated 'highly relevant' by 87% of users." - Jackson Reed, Owner, Vita Sync Health
Is on-device AI right for your organization?
Worth 30 minutes? We'll walk you through what your field workflow and connectivity constraints mean for the project shape, and what a realistic scope looks like.
You'll leave with enough to run a planning meeting next week. No pitch deck.
If we're not the right team, we'll tell you who is.
Book a call with the Wednesday team
Frequently Asked Questions
Q: What pharmaceutical field workflows can be automated with AI?
High-volume, rule-bound, time-sensitive tasks: qualification and routing of inbound inquiries, FAQ and objection handling, status communication, document review and extraction, reporting and summarization, and personalized nurture sequences.
Q: How much does AI workflow automation reduce costs for pharmaceutical field teams?
50% reduction in handling time per unit of work is the benchmark Wednesday guarantees in the evaluation sprint. At scale, companies automating 70% of intake workflow handle 3–5x volume with the same headcount.
Q: How long does AI automation for pharmaceutical field take to build?
Evaluation sprint: 2 weeks — audit of current workflow, map of interaction types, working prototype for top 3 use cases. If the prototype shows the 50% path, the build sprint follows. Full production: 6–10 weeks.
Q: What does AI workflow automation cost?
The evaluation sprint is fixed-price. If the prototype doesn't demonstrate a clear path to 50% cost reduction, you don't pay for the build. Wednesday has not had to stop an engagement at the prototype stage.
Q: How does AI automation handle edge cases?
The AI handles 70–80% of routine interactions. Edge cases — requiring judgment or missing a clear answer — are escalated to a human with full context: the AI's interaction history, what it tried, why it escalated. The human handling an escalation has more context, not less.
Top comments (0)